Avid Bioservices, Inc.
DelistedCIK 704562fmd_08HXZ551C5CR23WSVD7E8GJTGNManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: May 01, 2009 to Oct 31, 2024, 59 periods
Latest annual · FY2024
Millions- Total revenues
- 140
- Gross profit
- 7
- Operating income
- (19)
- Net income
- (141)
- Free cash flow
- (21)
Latest quarter · Q2 FY2025
Millions- Total revenues
- 33
- Gross profit
- (2)
- Operating income
- (13)
- Net income
- (17)
- Free cash flow
- 1
Bulls and bears
Loading
News summary
An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.
AI-written
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2021 to FY2024
- +13.4%
- Revenue, 5 yearsFY2019 to FY2024
- +21.2%
- Net income, 5 yearsFY2019 to FY2024
- n/m
Avid Bioservices, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Revenue | $139.9 million | $149.3 million | -6.3% | 10-K 2024-07-02 · proof |
| Gross profit | $7.3 million | $31.5 million | -76.8% | 10-K 2024-07-02 · proof |
| Operating income | -$18.7 million | $3.6 million | -618.7% | 10-K 2024-07-02 · proof |
| Net income | -$140.8 million | $259,000 | -54,444.8% | 10-K 2024-07-02 · proof |
| Cash from operating activities | $11 million | -$12.7 million | 10-K 2024-07-02 · proof | |
| Free cash flow | -$20.9 million | -$90.5 million | 10-K 2024-07-02 · proof | |
| Total assets | $336.6 million | $451.6 million | -25.5% | 10-K 2024-07-02 · proof |
| Total liabilities | $275.7 million | $262.4 million | +5.1% | 10-K 2024-07-02 · proof |
| Cash and cash equivalents | $38.1 million | $38.5 million | -1.1% | 10-K 2024-07-02 · proof |
- What was Avid Bioservices, Inc.'s revenue in fiscal 2024?
- Avid Bioservices, Inc. reported revenue of $139.9 million for fiscal 2024 (the year ended Apr 30, 2024), against $149.3 million the year before (-6.3%). Source: the 10-K filed with the SEC on Jul 2, 2024. SEC
- What was Avid Bioservices, Inc.'s gross profit in fiscal 2024?
- Avid Bioservices, Inc. reported gross profit of $7.3 million for fiscal 2024 (the year ended Apr 30, 2024), against $31.5 million the year before (-76.8%). Source: the 10-K filed with the SEC on Jul 2, 2024. SEC
- What was Avid Bioservices, Inc.'s operating income in fiscal 2024?
- Avid Bioservices, Inc. reported operating income of -$18.7 million for fiscal 2024 (the year ended Apr 30, 2024), against $3.6 million the year before (-618.7%). Source: the 10-K filed with the SEC on Jul 2, 2024. SEC
- What was Avid Bioservices, Inc.'s net income in fiscal 2024?
- Avid Bioservices, Inc. reported net income of -$140.8 million for fiscal 2024 (the year ended Apr 30, 2024), against $259,000 the year before (-54,444.8%). Source: the 10-K filed with the SEC on Jul 2, 2024. SEC
- What was Avid Bioservices, Inc.'s cash from operating activities in fiscal 2024?
- Avid Bioservices, Inc. reported cash from operating activities of $11 million for fiscal 2024 (the year ended Apr 30, 2024), against -$12.7 million the year before. Source: the 10-K filed with the SEC on Jul 2, 2024. SEC
- What was Avid Bioservices, Inc.'s free cash flow in fiscal 2024?
- Avid Bioservices, Inc. reported free cash flow of -$20.9 million for fiscal 2024 (the year ended Apr 30, 2024), against -$90.5 million the year before. Source: the 10-K filed with the SEC on Jul 2, 2024. SEC
- What are Avid Bioservices, Inc.'s total assets?
- As of Apr 30, 2024, Avid Bioservices, Inc. reported total assets of $336.6 million, against $451.6 million a year earlier (-25.5%). Source: the 10-K filed with the SEC on Jul 2, 2024. SEC
- What are Avid Bioservices, Inc.'s total liabilities?
- As of Apr 30, 2024, Avid Bioservices, Inc. reported total liabilities of $275.7 million, against $262.4 million a year earlier (+5.1%). Source: the 10-K filed with the SEC on Jul 2, 2024. SEC
- What are Avid Bioservices, Inc.'s cash and cash equivalents?
- As of Apr 30, 2024, Avid Bioservices, Inc. reported cash and cash equivalents of $38.1 million, against $38.5 million a year earlier (-1.1%). Source: the 10-K filed with the SEC on Jul 2, 2024. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:704562&period_type=annual&limit=5"Information only, not investment advice.